Zobrazeno 1 - 2 of 2 pro vyhledávání: '"Nayumi Shibazaki"'
1
Akademický článek
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
Autor: Hiroaki Okamoto, Nayumi Shibazaki, Takeshi Yoshimura, Toyonobu Uzawa, Toshitsugu Sugimoto
Publikováno v: Osteoporosis and Sarcopenia, Vol 6, Iss 1, Pp 15-19 (2020)
Objectives: On July 20, 2012, the European Medicines Agency (EMA) provided a recommendation that limits the long-term use of calcitonin. Based on this recommendation, we investigate the presence or absence of a cancer diagnosis in subjects who partic
Externí odkaz: https://doaj.org/article/2c30e8c3e63e453490b0c999f4853797
Zobrazit plný text záznamu
2
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
Autor: Takeshi Yoshimura, Nayumi Shibazaki, Hiroaki Okamoto, Toyonobu Uzawa, Toshitsugu Sugimoto
Publikováno v: Osteoporosis and Sarcopenia, Vol 6, Iss 1, Pp 15-19 (2020)
Osteoporosis and Sarcopenia
Objectives: On July 20, 2012, the European Medicines Agency (EMA) provided a recommendation that limits the long-term use of calcitonin. Based on this recommendation, we investigate the presence or absence of a cancer diagnosis in subjects who partic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd4dc6fb6953b7ce82eb94dea108e81
http://www.sciencedirect.com/science/article/pii/S2405525520300157
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje